Research ArticleGraft-Versus-Host Disease

Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant

See allHide authors and affiliations

Science Translational Medicine  20 Sep 2017:
Vol. 9, Issue 408, eaan3085
DOI: 10.1126/scitranslmed.aan3085

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article